Many new challenges have arisen in the area of oncology clinical
trials. New cancer therapies are often based on cytostatic or
targeted agents, which pose new challenges in the design and
analysis of all phases of trials. The literature on adaptive trial
designs and early stopping has been exploding. Inclusion of
high-dimensional data and imaging techniques have become common
practice, and statistical methods on how to analyse such data have
been refined in this area. A compilation of statistical topics
relevant to these new advances in cancer research, this third
edition of Handbook of Statistics in Clinical Oncology focuses on
the design and analysis of oncology clinical trials and
translational research.
Addressing the many challenges that have arisen since the
publication of its predecessor, this third edition covers the
newest developments involved in the design and analysis of cancer
clinical trials, incorporating updates to all four parts:
- Phase I trials: Updated recommendations regarding the standard
3 + 3 and continual reassessment approaches, along with new
chapters on phase 0 trials and phase I trial design for targeted
agents.
- Phase II trials Updates to current experience in single-arm and
randomized phase II trial designs. New chapters include phase II
designs with multiple strata and phase II/III designs.
- Phase III trials Many new chapters include interim analyses and
early stopping considerations, phase III trial designs for targeted
agents and for testing the ability of markers, adaptive trial
designs, cure rate survival models, statistical methods of imaging,
as well as a thorough review of software for the design and
analysis of clinical trials.
- Exploratory and high-dimensional data analyses All chapters in
this part have been thoroughly updated since the last edition. New
chapters address methods for analyzing SNP data and for developing
a score based on gene expression data. In addition, chapters on
risk calculators and forensic bioinformatics have been added.
Accessible to statisticians and oncologists interested in
clinical trial methodology, the book is a single-source collection
of up-to-date statistical approaches to research in clinical
oncology.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!